Emcure Pharma includes 4 new independent directors
New Delhi: Emcure Pharmaceuticals on Tuesday said it has strengthened its board with the inclusion of four new independent directors, including former Foreign Secretary Vijay Keshav Gokhale. The others who have joined the company''s board are Shailesh Ayyangar, Hitesh Jain and Vidya Yeravdekar.
Earlier this year, Berjis Desai had taken over as the chairman of Emcure Board. The company has had a long-standing tradition of appointing a Chairman from amongst its independent directors since 1997.
"We are delighted to have highly accomplished industry stalwarts as part of our board. New members'' combined experience and wider perspective from their respective fields, will play an instrumental role in strengthening our strategic operations to grow in domestic and international markets," Emcure Pharmaceuticals Managing Director & CEO Satish Mehta said in a statement.
The drug firm aims to further augment its strengths as one of the fastest growing pharmaceutical companies in India with a global reach of over 70 countries across the world.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.